As workforce turnover reshapes the industry, how can organisations preserve the knowledge that drives scientific progress?

In high-mix environments, inspection systems must first be flexible – everything else builds on that foundation

Every artificial intelligence-assisted conclusion that makes it outside the walls of an R&D organisation is a scientific claim that eventually has to stand on its own

As more and more cell therapies move from experimental treatments to commercial realities, manufacturing remains the primary bottleneck to patient access

As regulators increasingly focus on individual accountability, can manufacturing leaders afford to treat data governance as a back-office function?

Will the next generation of blockbuster therapies be won by science alone or by the speed of manufacturing execution?

A wave of small interfering RNA therapeutics targeting prevalent cardiometabolic diseases is anticipated to drive active pharmaceutical ingredients demand beyond the scale that existing manufacturing models were designed to support. Meeting this demand will require coordinated advances in manufacturing technology and supply chain structure alongside substantial investment in global production capacity

In the fast-paced, competitive world of generics manufacturing, processes such as integrated dissolution-absorption testing can mean the difference between first to market and obscurity